Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Covance Inc.    CVD   US2228161004

COVANCE INC. (CVD)

23
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 
Latest news on COVANCE INC.
10/17 COVANCE : Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadershi..
10/08 COVANCE : Invites You to Join the Webcast of Its Third Quarter 2014 Financial Re..
09/18 COVANCE : and Frenova Renal Research Establish
09/07 COVANCE : To Present At The Morgan Stanley Global Healthcare Conference
08/26 COVANCE : Transitioning from Bench into Clinical Phase, new webinar hosted by Xt..
08/07 COVANCE : Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro..
08/01 COVANCE : Management's Discussion and Analysis of Financial Condition and Result..
07/30 COVANCE : Financial Results, Investor Meeting Schedule, Dividend Declaration, an..
07/30 COVANCE : Results of Operations and Financial Condition, Financial Statements an..
07/30 COVANCE : Invites You to Join the Webcast of Its Second Quarter 2014 Financial R..
07/29 COVANCE : Reports Second Quarter Net Revenue Growth of 8.0% to $639 Million, Pro..
07/09 COVANCE : Increases its Medical and Scientific Leadership with Two Senior-Level ..
07/02 COVANCE : C O R R E C T I O N -- Covance Inc./
06/30 COVANCE : New Laws, Pricing of Offering, Recognitions, Donations, and Upcoming C..
06/27 COVANCE : MarketPlace, a New Solution to Expedite Biopharmaceutical Development
06/26 COVANCE : Invites You to Join the Webcast of Its Second Quarter 2014 Financial R..
06/25 COVANCE : C O R R E C T I O N -- Covance Inc./
06/24 COVANCE : MarketPlace, a New Solution to Expedite Biopharmaceutical Development
06/09 COVANCE : To Present At The William Blair 34th Annual Growth Stock Conference
06/08 COVANCE : To Present At The Goldman Sachs 35th Annual Global Healthcare Conferen..
06/06 COVANCE : Entry into a Material Definitive Agreement, Creation of a Direct Finan..
06/01 COVANCE : To Present At The Jefferies 2014 Global Healthcare Conference
05/20 COVANCE : Results Healthcare Advises Medaxial on Acquisition by Covance
05/19 COVANCE : Acquires Medaxial
05/18 COVANCE : to Present at the UBS Global Healthcare Conference
05/12 COVANCE : To Present At The Bank Of America Merrill Lynch Health Care Conference
05/09 COVANCE : Change in Directors or Principal Officers, Submission of Matters to a ..
05/07 COVANCE : Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro ..
05/07 COVANCE : and Lilly Honored with Alliance Excellence Award
05/07 COVANCE : Launches New Brand: Solutions Made Real™
05/05 COVANCE : to Present at The Baird 2014 Growth Stock Conference
05/05 COVANCE : Management's Discussion and Analysis of Financial Condition and Result..
05/02 COVANCE : Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro ..
05/01 COVANCE : Results of Operations and Financial Condition, Financial Statements an..
05/01 COVANCE : Launches New Brand: Solutions Made Real™
05/01 COVANCE : Launches New Brand: Solutions Made Real(TM)
05/01 COVANCE : Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro ..
04/30 COVANCE : and Lilly Honored with Alliance Excellence Award
04/28 COVANCE : DIA Webinar With FDA and Covance to Examine Risk-Based Monitoring
04/08 COVANCE : Big Data Experts from Covance, Gilead and Johnson-Johnson to Keynote a..
04/03 COVANCE : Invites You to Join the Webcast of Its First Quarter 2014 Financial Re..
03/25 COVANCE : expands Global Biologics Capabilities
03/12 COVANCE : To Present At The Raymond James 35th Annual Institutional Investors Co..
03/03 COVANCE INC. : Covance To Present At The Raymond James 35th Annual Institutional..
02/27 COVANCE INC. : COVANCE INC - 10-K - Management's Discussion and Analysis of Fina..
02/24 COVANCE INC. : Covance To Present At The Citi 2014 Global Healthcare Conference
02/24 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Change in Directors or Princip..
02/12 COVANCE INC. : Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro F..
02/11 COVANCE INC. : Covance to Present at the Leerink Swann 2014 Global Healthcare Co..
02/04 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Results of Operations and Fina..
02/04 COVANCE INC. : Covance Reports Fourth Quarter Net Revenue Of $623 Million, Pro F..
01/23 COVANCE INC. : Covance To Open Nutritional Chemistry And Food Safety Site In Har..
01/21 COVANCE INC. : Covance Appoints Dr. Barry J. Goldstein to Lead Expanded Cardiova..
01/12 COVANCE INC. : Covance to Present at the 32nd Annual J. P. Morgan Healthcare Con..
01/07 COVANCE INC. : Covance shares rise following analyst upgrade
01/07 COVANCE INC. : Covance shares rise following analyst upgrade
01/02 COVANCE INC. : Invites You to Join the Webcast of Its Fourth Quarter 2013 Financ..
2013 COVANCE INC. : Supply of Tab. SelokenXL 25 mg Tab.
2013 COVANCE INC. : Covance Board Authorizes $100M Stock Buyback
2013 COVANCE INC. : Covance Board Authorizes $100 Million Stock Buyback
2013 COVANCE INC. : Court Orders, Stock Price Movements, FDA Approvals and Strategic ..
2013 Covance To Present At The Credit Suisse Healthcare Conference
2013 COVANCE INC. : Covance To Present At The Credit Suisse Healthcare Conference
2013 COVANCE INC FILES (8-K) Disclosing Creation of a Direct Financial Obligation ..
2013 COVANCE INC. : COVANCE INC FILES (8-K) Disclosing Creation of a Direct Financial..
2013 COVANCE INC. : Covance NeoGenomics Enter Strategic Alliance for Anatomic Patholo..
2013 Covance NeoGenomics Enter Strategic Alliance for Anatomic Pathology and Speci..
2013 COVANCE INC. : Covance Central Laboratories and NeoGenomics Enter into Exclusive..
2013DJCAXTON ASSOCIATES LP 3Q 13F : Largest Eliminations
2013DJCAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30 -2-
2013DJCAXTON ASSOCIATES LP 3Q 13F : Holdings As Of Sep 30
2013 COVANCE INC. : Covance To Present At The Credit Suisse Healthcare Conference
2013 COVANCE INC. : Covance and Pathoquest Establish Exclusive Collaboration to Provi..
2013 COVANCE INC. : Covance Reports Third Quarter Net Revenue Of $607 Million, Pro Fo..
2013COVANCE INC. : quaterly earnings release
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Covance Inc. Technical Analysis Chart | CVD | US2228161004 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF